Microsoft PowerPoint - Physics Bucharest

545 / 1542

Planning studies:
Improved dose distribution → clinical benefit?
 Organ avoided  less toxicity?
 Better target coverage  better tumor control? Or maybe worse?
 Lower toxicity  dose-escalation?
 …
Randomized controlled trials
IMRT vs. Non-IMRT?
25
Clinical use of IMRT: What’s the scientific evidence?
Evidence